These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36851532)

  • 1. Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.
    Pandey P; Al Rumaih Z; Kels MJT; Ng E; Kc R; Malley R; Chaudhri G; Karupiah G
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia.
    Pandey P; Al Rumaih Z; Kels MJT; Ng E; Kc R; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
    Ye Y; Wang H; Liu J; Zhao F; Xu P
    Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.
    Cheemarla NR; Watkins TA; Mihaylova VT; Foxman EF
    J Infect Dis; 2024 May; 229(5):1430-1434. PubMed ID: 37722683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumour necrosis factor to ameliorate viral pneumonia.
    Pandey P; Karupiah G
    FEBS J; 2022 Feb; 289(4):883-900. PubMed ID: 33624419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qingjin Huatan decoction protects mice against influenza a virus pneumonia via the chemokine signaling pathways.
    Liu M; Zhao F; Xu J; Zhu X; Zhao Y; Wen R; Anirudhan V; Rong L; Tian J; Cui Q
    J Ethnopharmacol; 2023 Dec; 317():116745. PubMed ID: 37336335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
    Ji S; Bai Q; Wu X; Zhang DW; Wang S; Shen JL; Fei GH
    Biomed Pharmacother; 2020 Jan; 121():109652. PubMed ID: 31734578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice.
    Liu W; Ren X; Wang Q; Zhang Y; Du J
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):159-167. PubMed ID: 32865668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.
    Lai YN; Li Y; Fu LC; Zhao F; Liu N; Zhang FX; Xu PP
    J Med Virol; 2017 Jul; 89(7):1158-1167. PubMed ID: 27966790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung.
    Wong ZX; Jones JE; Anderson GP; Gualano RC
    Influenza Other Respir Viruses; 2011 Sep; 5(5):343-50. PubMed ID: 21668689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways.
    Dai JP; Wang QW; Su Y; Gu LM; Zhao Y; Chen XX; Chen C; Li WZ; Wang GF; Li KS
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29057806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
    Boianelli A; Sharma-Chawla N; Bruder D; Hernandez-Vargas EA
    Front Cell Infect Microbiol; 2016; 6():60. PubMed ID: 27379214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.
    Shi X; Zhou W; Huang H; Zhu H; Zhou P; Zhu H; Ju D
    Crit Care; 2013 Dec; 17(6):R301. PubMed ID: 24373231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral burden, inflammatory milieu and CD8
    Nüssing S; Mifsud E; Hensen L; Koutsakos M; Wang Z; Kedzierski L; Mercuri F; Rossignol JF; Hurt AC; Kedzierska K
    Influenza Other Respir Viruses; 2020 Nov; 14(6):678-687. PubMed ID: 32588557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections.
    Hulme KD; Noye EC; Short KR; Labzin LI
    Front Immunol; 2021; 12():770066. PubMed ID: 34777390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
    Ma Q; Huang W; Zhao J; Yang Z
    J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.